A new generation has been born. "Generation Alpha" is the latest term denoting a distinct group of people born in a specific ...

The clinical characteristics of 152 children under the age of 15 with severe beta-thalassemia are summarized in Table 1. The median age was 4 years (IQR: 3–6 years), with 108 male and 44 female ...

In this article, we will be taking a look at the 7 most profitable biotech stocks to buy right now. With improved market conditions, innovative breakthroughs, and more investor interest, the ...

The Emirates Drug Establishment (EDE) in the UAE has granted market authorization for CASGEVY to treat patients aged 12 years and older who suffer from sickle cell disease with recurrent ...

The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in ...

This achievement opens new horizons and offers innovative treatment for patients suffering from sickle cell disease (SCD) and transfusion dependent beta-thalassemia (TDT), positioning Abu Dhabi as a ...

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring ...

He was receiving chemotherapy at the same children’s hospital where I saw my hematologist for sickle beta thalassemia. For the rest of the ... became a member of Alpha Kappa Alpha Sorority, ...

This makes low Beta funds a preferred choice for conservative investors who want stability in their portfolio. Check 10 Mutual Funds that fell least in the last 6 months during this stock market fall.